SEARCH
COVAXIN overall 77.8% effective in Phase-3 trial : Bharat Biotech
NYOOOZ TV
2021-07-03
Views
122
Description
Share / Embed
Download This Video
Report
Bharat Biotech's Covaxin is overall 77.8 percent effective against Covid, the vaccine maker tweeted today, citing the data from the third phase of clinical trials.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x82ffie" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
01:40
Bharat Biotech: कोवाक्सिन के फेज 3 ट्रायल का डाटा आया | Covaxin Phase 3 Trail 77.8 Percent Efficacy
02:22
Bharat Biotech claims 77.8% efficacy for Covaxin in Phase 3 trials
02:13
Covaxin is 77.8% effective against Covid-19, claims Bharat Biotech: Details | Oneindia News
10:06
कोवॅक्सिन ८१% प्रभावी! घेऊ की थांबू? Dr Ravi Godse On Covaxin | Bharat Biotech Covaxin 81% Effective
00:53
Bharat Biotech concludes phase 3 Covaxin trial, claims 77.8% efficacy against COVID 19 _ TV9News
02:02
Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News
05:46
Covaxin Shows 81 Percent Efficacy In Phase 3 Clinical Trial | Bharat Biotech
15:51
Mamata Banerjee moves SC; Bharat Biotech submits Covaxin Phase 3 trial data, other headlines
01:35
Bharat Biotech Submits Covaxin Phase-III Clinical Trial Data To DCGI
02:20
COVID-19 Vaccine Update: Covaxin By Bharat Biotech Cleared For Phase 3 Trials By DCGI
03:11
Covaxin Phase 3 Interim Trial Data: Results Show 81% Efficacy Rate, Claims Bharat Biotech
01:01
Bharat Biotech announces phase 3 results of Covaxin, says it demonstrates interim clinical efficacy of 81%
